- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
- FuncS
Supplier Data
Functional Studies - Bordetella pertussis toxin (PT) IgA ELISA kit (AB247192)
Typical Standard Curve – Representative standard curve using ab247192 using the point to point function.
Reactivity 정보
제품 세부 정보
Bordetella pertussis toxin (PT) IgA ELISA kit (ab247192) is designed for the quantitative determination of IgA class antibodies against Bordetella pertussis toxin antigens in human serum or plasma (citrate, heparin).
The quantitative immunoenzymatic determination of specific antibodies is based on the ELISA (Enzyme-linked Immunosorbent Assay) technique. Microplates are coated with specific antigens to bind corresponding antibodies of the sample. After washing the wells to remove all unbound sample material a horseradish peroxidase (HRP) labelled conjugate is added. This conjugate binds to the captured antibodies. In a second washing step unbound conjugate is removed. The immune complex formed by the bound conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a blue reaction product. The intensity of this product is proportional to the amount of specific antibodies in the sample. Sulphuric acid is added to stop the reaction. This produces a yellow endpoint colour. Absorbance at 450/620 nm is read using an ELISA microwell plate reader.
Bordetella pertussis is a respiratory pathogen that causes pertussis, commonly known as whooping cough, a localized infection of the ciliated epithelium of the bronchial tree. Pertussis is characterized by a prolonged paroxysmal cough often accompanied by an inspiratory whoop. The disease affects mainly children, but adults have also been increasingly reported to be affected. The pathogen produces toxins which cause local damage to the cilia of epithelial cells, which leads to prolonged illness and pertussis. Disease presentation varies with age and history of previous exposure or vaccination. Severe disease is infrequent in healthy, vaccinated persons. Infants, particularly those who have not received the primary vaccination series against pertussis, are at risk for complications and mortality.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Precision
제품 구성
특성 및 보관 정보
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Pertussis toxin disrupts host immune responses and cellular signaling pathways. It is an important component of the ab5 toxin family where one A subunit and five B subunits form a complex to enter cells. The toxin binds to cell surface glycoproteins facilitating its uptake and subsequent inhibition of G-protein-coupled receptor (GPCR) signaling. This action interferes with a variety of intracellular processes ultimately leading to altered immune regulation and enhanced bacterial colonization.
Pathways
Pertussis toxin plays a significant role in the intracellular signaling pathways especially impacting the GPCR pathways. The toxin's catalytic subunit modifies the alpha subunit of inhibitory G-proteins (Gi) which prevents normal signal transduction from the GPCRs. This dysregulation impairs processes such as cyclic AMP (cAMP) regulation and immune response modulation. In the GPCR pathway B. pertussis toxin shows close functional relationships with other G-protein coupled components.
타겟 정보
Additional targets
대체 명칭 보기
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Multidisciplinary respiratory medicine 17:832 PubMed35865347
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com